News of the FDA’s investigation into the weight loss drug Alli caught parent company GlaxoSmithKline off guard. But in a recent article by Matthew Perrone in The Associated Press, pharma specialist Mark Senak
says it’s the type of action regulated companies should start to expect as the agency moves toward “a more pro-active public health stance.”
FDA Investigation Surprises Global Pharma Giant
Posted on September 11th, 2009 | More Agribusiness · Food & Beverage · Healthcare · Public Affairs
Related Posts
-
Leaked Documents Shed Light on More Than War in Afghanistan
Among obvious concerns, WikiLeaks’ release of more than 90,000 secret U.S. military documents relating to the war in Afghanistan will put the Obama administration’s “21st century statecraft” strategy to the test. The digital specialists from Public Affairs 2.0
take a look at what happens “when crisis communications takes on new meaning.”Posted on July 26th, 2010 | More Digital & Social Media · Public Affairs
-
Pharma Meet Facebook, Facebook Meet Pharma
Pharma specialist Mark Senak
talks about the pharmaceutical industry’s slow adoption of Facebook and explains why medical product manufacturers should take advantage of this “extremely important referral source.”Posted on July 20th, 2010 | More Digital & Social Media · Healthcare · Public Affairs
-
Is New Government App a Smart Idea?
According to the U.S. Department of Agriculture, its new smartphone app — which alerts consumers to the latest recall information — could prevent illness and even save lives. But pharma specialist Mark Senak
says putting a “report incident” feature in the hands of consumers could “create chaos.”Posted on July 14th, 2010 | More Healthcare · Mobile · Public Affairs
